Full year recurring revenue of $242.3 million, up 62% from prior
year
Second consecutive year with 59% GAAP operating
margin
Share buyback authorization increased by $200
million
SAN JOSE, Calif.--(BUSINESS WIRE)--
Tessera Technologies, Inc. (NASDAQ: TSRA) (the "Company" or "we") today
announced financial results for the fourth quarter and full year ending
December 31, 2015. Total revenue for the fourth quarter of 2015 was
$61.8 million, at the high end of the Company's guidance range of $60 to
$62 million. GAAP net income for the fourth quarter of 2015 was $22.8
million, or $0.44 per diluted share, and non-GAAP net income was $29.7
million, or $0.57 per diluted share.
"Our excellent fourth quarter results reflect the strength and stability
of our intellectual property and technology licensing model, the
market's ongoing adoption of FotoNation imaging technologies, and our
continued financial discipline," said Tom Lacey, Tessera's Chief
Executive Officer. "I'm excited about the array of growth opportunities
across all areas of our business, and we expect to maintain momentum
throughout 2016. Our focus on delivering value extends from our
collaborative business strategy to our capital allocation policy. In
2015 we returned more than $160 million to shareholders through
dividends and share repurchases, and our Board of Directors has approved
an additional $200 million for our share repurchase program."
Fourth Quarter 2015 Results
Total revenue was $61.8 million in the fourth quarter of 2015, compared
with revenue of $59.9 million in the fourth quarter of 2014. Recurring
revenue was $60.8 million in the fourth quarter of 2015, compared with
recurring revenue of $43.3 million in the fourth quarter of 2014. Fourth
quarter 2015 revenue included $1.0 million of episodic revenue, compared
with episodic revenue of $16.6 million in the fourth quarter of 2014.
Operating expenses were $28.4 million in the fourth quarter of 2015.
Operating expenses in the fourth quarter of 2014 were $13.0 million,
which included a gain of $11.9 million on the sale of long-lived assets.
Net income was $22.8 million, or $0.44 per diluted share, compared with
net income for the fourth quarter of 2014 of $37.1 million, or $0.69 per
diluted share. Net income for the fourth quarter of 2014 was favorably
impacted by the gain on sale of long-lived assets previously mentioned.
Non-GAAP net income for the fourth quarter of 2015 was $29.7 million, or
$0.57 per diluted share, compared with non-GAAP net income in the fourth
quarter of 2014 of $33.7 million, or $0.62 per diluted share. Non-GAAP
net income is defined as income and operating expenses adjusted for
discontinued operations, restructuring and other exit costs, acquired
intangible asset amortization, charges for acquired in-process research
and development, stock-based compensation expense, impairment charges on
long-lived assets and goodwill, and related tax effects.
Full Year 2015 Financial Results
Total revenue was $273.3 million for the year ended December 31, 2015,
as compared with $278.8 million for the year ended December 31, 2014.
Total recurring revenue for 2015 was $242.3 million as compared with
$149.8 million for 2014.
Operating expenses totaled $111.1 million for 2015 as compared with
$113.1 million for 2014 and operating margin was 59% for the second
consecutive year. Income from continuing operations was $117.1 million,
or $2.23 per diluted share in 2015, including a $6.3 million reversal of
a deferred tax valuation allowance, as compared with $174.9 million, or
$3.27 per diluted share in 2014, including a $64.7 million reversal of a
deferred tax valuation allowance. Non-GAAP net income per share was
$2.55 for 2015, compared with $2.26 for 2014.
Balance Sheet
Total current assets were $411.7 million as of December 31, 2015, a
decrease of $63.9 million from December 31, 2014. Cash, cash equivalents
and short-term investments were $381.7 million as of December 31, 2015,
a decrease of $52.7 million from December 31, 2014. The decline in cash
for the fiscal year was due to stock repurchases of $119.2 million, the
payment of $41.7 million of dividends and the third quarter 2015
acquisition of Ziptronix, Inc. for $38.6 million, largely offset by cash
generated from operating activities.
Dividends
On December 15, 2015, the Company paid $10.2 million to stockholders of
record as of November 24, 2015, for the quarterly cash dividend of $0.20
per share of common stock.
Additionally, on January 27, 2016, the Board of Directors approved a
regular quarterly dividend of $0.20 per share of common stock, payable
on March 16, 2016 to stockholders of record on February 24, 2016.
Stock Repurchase Program
During the fourth quarter of 2015, the Company repurchased approximately
776 thousand shares of common stock for an aggregate amount of $25.3
million, bringing total repurchases for fiscal 2015 to approximately 3.3
million shares for an aggregate amount of $119.2 million. These
purchases were executed under the Company's stock repurchase program. As
of December 31, 2015, the Company had approximately $25.9 million
remaining under its current repurchase program. Subsequently, on January
27, 2016, the Board of Directors approved an additional $200 million
share repurchase authorization.
Financial Guidance
For the first quarter of 2016, the Company's guidance is as follows:
-
Total revenue is expected to be between $55 million and $59 million;
-
GAAP earnings per share are expected to be between $0.30 and $0.35 per
diluted share;
-
Non-GAAP earnings per share are expected to be between $0.41 and $0.46
per diluted share.
The Company's full-year 2016 total revenue guidance is between $250
million and $270 million.
"The total revenue guidance range for 2016 does not contemplate the
completion of all open legal and greenfield matters or significant
upside to the FotoNation business," noted Robert Andersen, Tessera's CFO.
Conference Call Information
The Company will hold its fourth quarter ended December 31, 2015,
earnings conference call at 2:00 PM Pacific time (5:00 PM Eastern time)
on Tuesday, February 2. To access the call in the U.S., please dial
(888) 723-9308, and for international callers dial (615) 489-8916,
approximately 10 minutes prior to the start of the conference call. The
conference ID is 23018308. The conference call will also be broadcast
live over the Internet at www.tessera.com
and available for replay for 90 days at www.tessera.com.
A slide presentation accompanies the webcast. In addition, a replay of
the call will be available via telephone for two business days,
beginning two hours after the call. To listen to the telephone replay in
the U.S., please dial (855) 859-2056. International callers please dial
(404) 537-3406. Enter access code 23018308.
Safe Harbor Statement
This document contains forward-looking statements, which are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements involve risks
and uncertainties that could cause actual results to differ
significantly from those projected, particularly with respect to the
Company's financial results and guidance and growth opportunities.
Material factors that may cause results to differ from the statements
made include the plans or operations relating to the businesses of the
Company; market or industry conditions; changes in patent laws,
regulation or enforcement, or other factors that might affect the
Company's ability to protect or realize the value of its intellectual
property; the expiration of license agreements and the cessation of
related royalty income; the failure, inability or refusal of licensees
to pay royalties; initiation, delays, setbacks or losses relating to the
Company's intellectual property or intellectual property litigations, or
invalidation or limitation of key patents; fluctuations in operating
results due to the timing of new license agreements and royalties, or
due to legal costs; the risk of a decline in demand for semiconductors
and products utilizing FotoNation technologies; failure by the industry
to use technologies covered by the Company's patents; the expiration of
the Company's patents; the Company's ability to successfully complete
and integrate acquisitions of businesses; the risk of loss of, or
decreases in production orders from, customers of acquired businesses;
financial and regulatory risks associated with the international nature
of the Company's businesses; failure of the Company's products to
achieve technological feasibility or profitability; failure to
successfully commercialize the Company's products; changes in demand for
the products of the Company's customers; limited opportunities to
license technologies due to high concentration in the markets for
semiconductors and related products and smartphone imaging; and the
impact of competing technologies on the demand for the Company's
technologies. You are cautioned not to place undue reliance on the
forward-looking statements, which speak only as of the date of this
release. The Company's filings with the Securities and Exchange
Commission, including its Annual Report on Form 10-K for the year ended
Dec. 31, 2014, and its Quarterly Report on Form 10-Q for the quarter
ended Sept. 30, 2015, include more information about factors that could
affect the Company's financial results. The Company assumes no
obligation to update information contained in this press release.
Although this release may remain available on the Company's website or
elsewhere, its continued availability does not indicate that the Company
is reaffirming or confirming any of the information contained herein.
About Tessera Technologies, Inc.
Tessera Technologies, Inc., including its Invensas, FotoNation and
Ziptronix subsidiaries, licenses its technologies and intellectual
property to customers for use in areas such as mobile computing and
communications, memory and data storage, and 3DIC technologies, among
others. Our technologies include semiconductor packaging and
interconnect solutions, and products and solutions for mobile and
computational imaging, including our FaceToolsTM, FacePowerTM,
FotoSavvyTM, DigitalApertureTM, LifeFocusTM,
face beautification, red-eye removal, High Dynamic Range, autofocus,
panorama, and image stabilization intellectual property. For more
information call 1.408.321.6000 or visit www.tessera.com.
Tessera, the Tessera logo, FotoNation, the FotoNation logo, Ziptronix,
the Ziptronix logo, FaceSavvy, FaceTools, FacePower, DigitalAperture,
and LifeFocus are trademarks or registered trademarks of affiliated
companies of Tessera Technologies, Inc. in the United States and other
countries. All other company, brand and product names may be trademarks
or registered trademarks of their respective companies.
Recurring and Episodic Revenue
Recurring revenue is defined as revenue from payments made pursuant to a
license agreement or other agreement that are scheduled to occur over at
least one year of time. Episodic revenue is revenue other than revenue
payable over at least one year pursuant to a contract. Episodic revenue
includes non-recurring engineering fees, initial license fees, back
payments resulting from audits, damages awards from courts or other
tribunals, and lump sum settlement payments. Although the royalty
revenue reported by the Company's licensees on a quarterly basis is
generally not assured, for ease of reference, the Company refers to
these revenues as "recurring revenue".
Importantly, a source of episodic revenue may become a source of
recurring revenue, when, for example, a company settles litigation with
the Company by paying a settlement amount and entering into a license
agreement that calls for an initial license fee and ongoing royalty
payment over several years. In that scenario, the settlement amount
would be episodic revenue, as would the initial license fee, and the
ongoing royalties would be recurring revenue.
Discontinued Operations
In January of 2014, the Company announced the cessation of all mems|cam
manufacturing operations. This was the Company's last manufacturing
operation. The Company has classified the expenses of its DigitalOptics
business as discontinued operations starting with the first quarter of
2014, and also reclassified results from this business to discontinued
operations for all prior reporting periods.
Non-GAAP Financial Measures
In addition to disclosing financial results calculated in accordance
with U.S. Generally Accepted Accounting Principles (GAAP), the Company's
earnings release contains non-GAAP financial measures adjusted for
discontinued operations, either one-time or ongoing non-cash acquired
intangibles amortization charges, acquired in-process research and
development, all forms of stock-based compensation, impairment charges
on long-lived assets and goodwill, gain on sale of patents,
restructuring and other related exit costs, and related tax effects. The
non-GAAP financial measures also exclude the effects of FASB Accounting
Standards Codification 718, "Stock Compensation" upon the number
of diluted shares used in calculating non-GAAP earnings per share.
Management believes that the non-GAAP measures used in this release
provide investors with important perspectives into the Company's ongoing
business performance. The non-GAAP financial measures disclosed by the
Company should not be considered a substitute for, or superior to,
financial measures calculated in accordance with GAAP, and the financial
results calculated in accordance with GAAP and reconciliations to those
financial statements should be carefully evaluated. The non-GAAP
financial measures used by the Company may be calculated differently
from, and therefore may not be comparable to, similarly titled measures
used by other companies. All financial data is presented on a GAAP basis
except where the Company indicates its presentation is on a non-GAAP
basis.
Set forth below are reconciliations of non-GAAP net income (loss) to the
Company's reported GAAP net income (loss) and non-GAAP earnings per
share to GAAP earnings per share guidance for the first quarter of 2016.
|
|
|
|
|
TESSERA TECHNOLOGIES, INC.
|
|
CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
|
2015
|
|
|
|
|
|
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
$
|
22,599
|
|
|
|
|
|
$
|
50,908
|
|
|
|
Short-term investments
|
|
|
|
|
|
359,145
|
|
|
|
|
|
|
383,513
|
|
|
|
Accounts receivable, net
|
|
|
|
|
|
1,784
|
|
|
|
|
|
|
4,478
|
|
|
|
Short-term deferred tax assets
|
|
|
|
|
_
|
|
|
|
|
|
19,334
|
|
|
|
Other current assets
|
|
|
|
|
|
28,130
|
|
|
|
|
|
|
17,277
|
|
|
|
|
|
Total current assets
|
|
|
|
|
|
411,658
|
|
|
|
|
|
|
475,510
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
|
|
|
3,748
|
|
|
|
|
|
|
4,322
|
|
|
Intangible assets, net
|
|
|
|
|
|
95,089
|
|
|
|
|
|
|
72,925
|
|
|
Long-term deferred tax assets
|
|
|
|
|
|
15,649
|
|
|
|
|
|
|
21,759
|
|
|
Other assets
|
|
|
|
|
|
|
13,208
|
|
|
|
|
|
|
2,607
|
|
|
|
|
|
Total assets
|
|
|
|
|
$
|
539,352
|
|
|
|
|
|
$
|
577,123
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
|
|
$
|
1,090
|
|
|
|
|
|
$
|
3,509
|
|
|
|
Accrued legal fees
|
|
|
|
|
|
2,621
|
|
|
|
|
|
|
4,143
|
|
|
|
Accrued liabilities
|
|
|
|
|
|
10,262
|
|
|
|
|
|
|
13,284
|
|
|
|
Deferred revenue
|
|
|
|
|
|
6,805
|
|
|
|
|
|
|
10,217
|
|
|
|
Other current liabilities
|
|
|
|
|
|
-
|
|
|
|
|
|
|
2,873
|
|
|
|
|
|
Total current liabilities
|
|
|
|
|
|
20,778
|
|
|
|
|
|
|
34,026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term deferred tax liabilities
|
|
|
|
|
|
255
|
|
|
|
|
|
|
187
|
|
|
Other long-term liabilities
|
|
|
|
|
|
3,162
|
|
|
|
|
|
|
1,551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
|
|
|
58
|
|
|
|
|
|
|
58
|
|
|
|
Additional paid-in capital
|
|
|
|
|
|
599,186
|
|
|
|
|
|
|
576,341
|
|
|
|
Treasury stock
|
|
|
|
|
|
(229,513
|
)
|
|
|
|
|
|
(106,231
|
)
|
|
|
Accumulated other comprehensive income
|
|
|
|
|
|
(1,437
|
)
|
|
|
|
|
|
(333
|
)
|
|
|
Retained earnings
|
|
|
|
|
|
146,863
|
|
|
|
|
|
|
71,524
|
|
|
|
|
|
Total stockholders' equity
|
|
|
|
|
|
515,157
|
|
|
|
|
|
|
541,359
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity
|
|
|
|
|
$
|
539,352
|
|
|
|
|
|
$
|
577,123
|
|
|
|
|
|
|
TESSERA TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
(in thousands, except per share amounts)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
|
Twelve Months Ended
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
2015
|
|
|
|
|
|
2014
|
|
|
|
|
|
|
|
2015
|
|
|
|
|
|
2014
|
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Royalty and license fees
|
|
|
|
|
$
|
61,836
|
|
|
|
|
$
|
59,924
|
|
|
|
|
|
|
$
|
273,300
|
|
|
|
|
$
|
278,807
|
|
|
|
Total revenues
|
|
|
|
|
|
61,836
|
|
|
|
|
|
59,924
|
|
|
|
|
|
|
|
273,300
|
|
|
|
|
|
278,807
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues
|
|
|
|
|
|
196
|
|
|
|
|
|
156
|
|
|
|
|
|
|
|
566
|
|
|
|
|
|
384
|
|
|
|
Research, development and other related costs
|
|
|
|
|
|
8,400
|
|
|
|
|
|
6,866
|
|
|
|
|
|
|
|
32,181
|
|
|
|
|
|
32,270
|
|
|
|
Selling, general and administrative
|
|
|
|
|
|
10,560
|
|
|
|
|
|
11,038
|
|
|
|
|
|
|
|
43,592
|
|
|
|
|
|
47,208
|
|
|
|
Amortization expense
|
|
|
|
|
|
6,051
|
|
|
|
|
|
4,699
|
|
|
|
|
|
|
|
20,624
|
|
|
|
|
|
18,471
|
|
|
|
Litigation expense
|
|
|
|
|
|
3,174
|
|
|
|
|
|
2,130
|
|
|
|
|
|
|
|
14,135
|
|
|
|
|
|
25,116
|
|
|
|
Restructuring, impairment of long-lived assets and other charges and
gain on sale of patents
|
|
|
|
|
|
--
|
|
|
|
|
|
(11,933
|
)
|
|
|
|
|
|
|
--
|
|
|
|
|
|
(10,338
|
)
|
|
|
Total operating expenses
|
|
|
|
|
|
28,381
|
|
|
|
|
|
12,956
|
|
|
|
|
|
|
|
111,098
|
|
|
|
|
|
113,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income from continuing operations
|
|
|
|
|
|
33,455
|
|
|
|
|
|
46,968
|
|
|
|
|
|
|
|
162,202
|
|
|
|
|
|
165,696
|
|
|
|
Other income and expense, net
|
|
|
|
|
|
1,260
|
|
|
|
|
|
449
|
|
|
|
|
|
|
|
3,432
|
|
|
|
|
|
1,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes from continuing operations
|
|
|
|
|
|
34,715
|
|
|
|
|
|
47,417
|
|
|
|
|
|
|
|
165,634
|
|
|
|
|
|
167,246
|
|
|
|
Provision for (benefit from) income taxes
|
|
|
|
|
|
11,870
|
|
|
|
|
|
11,098
|
|
|
|
|
|
|
|
48,517
|
|
|
|
|
|
(7,697
|
)
|
|
|
Income from continuing operations
|
|
|
|
|
|
22,845
|
|
|
|
|
|
36,319
|
|
|
|
|
|
|
|
117,117
|
|
|
|
|
|
174,943
|
|
|
|
Income (loss) from discontinued operations, net of tax
|
|
|
|
|
|
(33
|
)
|
|
|
|
|
771
|
|
|
|
|
|
|
|
(101
|
)
|
|
|
|
|
(4,489
|
)
|
|
|
Net income
|
|
|
|
|
$
|
22,812
|
|
|
|
|
$
|
37,090
|
|
|
|
|
|
|
$
|
117,016
|
|
|
|
|
$
|
170,454
|
|
|
|
Income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
$
|
0.45
|
|
|
|
|
$
|
0.69
|
|
|
|
|
|
|
$
|
2.26
|
|
|
|
|
$
|
3.31
|
|
|
|
Diluted
|
|
|
|
|
$
|
0.44
|
|
|
|
|
$
|
0.68
|
|
|
|
|
|
|
$
|
2.23
|
|
|
|
|
$
|
3.27
|
|
|
|
Income (loss) from discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
$
|
0.00
|
|
|
|
|
$
|
0.01
|
|
|
|
|
|
|
$
|
0.00
|
|
|
|
|
$
|
(0.08
|
)
|
|
|
Diluted
|
|
|
|
|
$
|
0.00
|
|
|
|
|
$
|
0.01
|
|
|
|
|
|
|
$
|
0.00
|
|
|
|
|
$
|
(0.08
|
)
|
|
|
Net income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
$
|
0.45
|
|
|
|
|
$
|
0.70
|
|
|
|
|
|
|
$
|
2.26
|
|
|
|
|
$
|
3.23
|
|
|
|
Diluted
|
|
|
|
|
$
|
0.44
|
|
|
|
|
$
|
0.69
|
|
|
|
|
|
|
$
|
2.23
|
|
|
|
|
$
|
3.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends declared per share
|
|
|
|
|
$
|
0.20
|
|
|
|
|
$
|
0.10
|
|
|
|
|
|
|
$
|
0.80
|
|
|
|
|
$
|
0.92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares used in per share
calculations-basic
|
|
|
|
|
|
50,817
|
|
|
|
|
|
52,758
|
|
|
|
|
|
|
|
51,802
|
|
|
|
|
|
52,819
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares used in per share
calculations-diluted
|
|
|
|
|
|
51,435
|
|
|
|
|
|
53,595
|
|
|
|
|
|
|
|
52,586
|
|
|
|
|
|
53,563
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TESSERA TECHNOLOGIES, INC.
|
|
RECONCILIATION TO NON-GAAP INCOME FROM CONTINUING OPERATIONS FROM
GAAP NET INCOME FROM CONTINUING OPERATIONS
|
|
(in thousands, except per share amounts)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
|
Twelve Months Ended
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
|
|
2015
|
|
|
|
|
|
2014
|
|
|
|
|
|
|
|
2015
|
|
|
|
|
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP income from continuing operations
|
|
|
|
|
|
|
|
$
|
22,845
|
|
|
|
|
$
|
36,319
|
|
|
|
|
|
|
$
|
117,117
|
|
|
|
|
$
|
174,943
|
|
|
|
Adjustments to GAAP net income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation - research, development and other related
costs
|
|
|
|
|
|
|
|
|
1,200
|
|
|
|
|
|
528
|
|
|
|
|
|
|
|
4,004
|
|
|
|
|
|
2,418
|
|
|
|
Stock-based compensation - selling, general and administrative
|
|
|
|
|
|
|
|
|
1,860
|
|
|
|
|
|
2,595
|
|
|
|
|
|
|
|
8,024
|
|
|
|
|
|
8,994
|
|
|
|
Amortization of acquired intangibles
|
|
|
|
|
|
|
|
|
6,051
|
|
|
|
|
|
4,699
|
|
|
|
|
|
|
|
20,624
|
|
|
|
|
|
18,471
|
|
|
|
Restructuring, impairment of long-lived assets and other charges and
gain on sale of patents
|
|
|
|
|
|
|
|
|
---
|
|
|
|
|
|
(11,933
|
)
|
|
|
|
|
|
|
---
|
|
|
|
|
|
(10,339
|
)
|
|
|
Non-GAAP tax adjustments and other
|
|
|
|
|
|
|
|
|
(2,302
|
)
|
|
|
|
|
1,461
|
|
|
|
|
|
|
|
(13,370
|
)
|
|
|
|
|
(71,227
|
)
|
|
|
Non-GAAP net income from continuing operations
|
|
|
|
|
|
|
|
$
|
29,654
|
|
|
|
|
$
|
33,669
|
|
|
|
|
|
|
$
|
136,399
|
|
|
|
|
$
|
123,260
|
|
|
|
Non-GAAP net income from continuing operations per common share -
diluted
|
|
|
|
|
|
|
|
$
|
0.57
|
|
|
|
|
$
|
0.62
|
|
|
|
|
|
|
$
|
2.55
|
|
|
|
|
$
|
2.26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP weighted average number of shares used in per share
calculations excluding the effects of stock-based compensation -
diluted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52,383
|
|
|
|
|
|
54,524
|
|
|
|
|
|
|
|
53,554
|
|
|
|
|
|
54,564
|
|
|
|
|
|
|
EPISODIC AND RECURRING REVENUE
|
|
(in thousands)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
|
|
|
Twelve Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
|
|
2015
|
|
|
|
2014
|
|
|
|
|
|
|
|
2015
|
|
|
|
2014
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Episodic
|
|
|
|
|
|
|
|
|
$ 1,000 |
|
|
|
$ 16,610 |
|
|
|
|
|
|
|
$ 31,000 |
|
|
|
$
|
128,982
|
|
|
Recurring
|
|
|
|
|
|
|
|
|
60,836
|
|
|
|
43,314
|
|
|
|
|
|
|
|
242,300
|
|
|
|
|
149,825
|
|
|
Total revenues
|
|
|
|
|
|
|
|
|
$ 61,836 |
|
|
|
$ 59,924 |
|
|
|
|
|
|
|
$ 273,300 |
|
|
|
$
|
278,807
|
|
|
|
|
|
TESSERA TECHNOLOGIES, INC.
RECONCILIATION FOR GUIDANCE ON
GAAP TO NON-GAAP EARNINGS PER SHARE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Low
|
|
|
|
|
|
|
High
|
|
Diluted earnings per share - GAAP
|
|
|
|
|
|
|
$
|
0.30
|
|
|
|
|
|
|
|
$
|
0.35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets
|
|
|
|
|
|
|
|
0.12
|
|
|
|
|
|
|
|
|
0.12
|
|
|
Stock based compensation
|
|
|
|
|
|
|
|
0.06
|
|
|
|
|
|
|
|
|
0.06
|
|
|
Subtotal GAAP adjustments
|
|
|
|
|
|
|
|
0.18
|
|
|
|
|
|
|
|
|
0.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact of income tax and share count
|
|
|
|
|
|
|
|
(0.07
|
)
|
|
|
|
|
|
|
|
(0.07
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect on earnings per share
|
|
|
|
|
|
|
|
0.11
|
|
|
|
|
|
|
|
|
0.11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share - non-GAAP
|
|
|
|
|
|
|
$
|
0.41
|
|
|
|
|
|
|
|
$
|
0.46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TSRA-E

View source version on businesswire.com: http://www.businesswire.com/news/home/20160202006585/en/
Company Contact:
The Piacente Group | Investor Relations
Don
Markley, 212-481-2050
tessera@tpg-ir.com
Source: Tessera Technologies, Inc.
News Provided by Acquire Media